Publications by authors named "J Kelman"
Importance: Acute respiratory failure (ARF) associated with antipsychotic use has been documented through case reports and population-based studies.
Objective: To assess whether the recent use of antipsychotics is associated with an increased risk of ARF in U.S.
Background: There is a paucity of data on treatment of osteoporosis in patients with advanced chronic kidney disease (CKD).
Objective: To assess the risk for emergently treated hypocalcemia with denosumab by stage of CKD and presence of CKD-mineral and bone disorder (CKD-MBD).
Design: Target trial emulation.
To characterize cannabis-related disorder medical encounter trends in the US Medicare population during 2017 to 2022. We conducted a descriptive study, which included 56 624 432 beneficiaries aged 65 years or older and 10 247 953 aged 18 to 64 years with disability. All were continuously enrolled in Medicare (Fee-for-Service or Advantage) for 183 or more days before the first day of the calendar year.
View Article and Find Full Text PDFBackground: Concerns have been raised regarding proton pump inhibitor (PPI) use and risk of severe coronavirus disease 2019 (COVID-19). Observational studies have yielded heterogeneous results and were subject to important methodological limitations.
Aims: To examine the association between the receipt of PPIs and risk of COVID-19 hospitalizations and severe in-hospital outcomes or death.
Article Synopsis
- A study was conducted using Medicare data to evaluate the effectiveness of a third COVID-19 vaccine dose among beneficiaries aged 65 and older during the Omicron variant surge.
- The results showed that 73.3% of the eligible individuals had received a third dose by March 2022, and it significantly reduced the risk of hospitalization and death, especially within the first 60 days.
- However, the added protection from the third dose declined after four months, highlighting the importance of ongoing vaccination efforts.